X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (25) 25
female (17) 17
index medicus (15) 15
male (15) 15
middle aged (14) 14
aged (12) 12
aged, 80 and over (9) 9
adult (8) 8
prospective studies (8) 8
cancer (7) 7
gastroenterology & hepatology (7) 7
mutation (7) 7
analysis (5) 5
disease progression (5) 5
prognosis (5) 5
carcinoma, renal cell - genetics (4) 4
kidney neoplasms - genetics (4) 4
kidney neoplasms - pathology (4) 4
management (4) 4
metastasis (4) 4
neoplasm metastasis (4) 4
oncology (4) 4
phenotype (4) 4
predictive value of tests (4) 4
survival (4) 4
tumors (4) 4
biochemistry & molecular biology (3) 3
carcinoma, renal cell - pathology (3) 3
care and treatment (3) 3
cell biology (3) 3
chemotherapy (3) 3
disease (3) 3
greece (3) 3
kaplan-meier estimate (3) 3
liver (3) 3
liver cirrhosis (3) 3
longitudinal studies (3) 3
medical colleges (3) 3
medicine, general & internal (3) 3
mortality (3) 3
patterns (3) 3
prevalence (3) 3
retrospective studies (3) 3
review (3) 3
treatment outcome (3) 3
5' untranslated regions (2) 2
alleles (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
apoptosis (2) 2
article subject (2) 2
biomarkers, tumor (2) 2
biopsy (2) 2
branched evolution (2) 2
cancer evolution (2) 2
carcinoma, renal cell (2) 2
case report (2) 2
cell carcinoma (2) 2
cervical cancer (2) 2
child (2) 2
chromosome instability (2) 2
chromosomes (2) 2
chromosomes, human, pair 3 (2) 2
chromosomes, human, pair 5 (2) 2
clear cell renal cell carcinoma (2) 2
clonal evolution (2) 2
coagulation disorders (2) 2
copy-number alterations (2) 2
dosage and administration (2) 2
ehlers-danlos syndrome (2) 2
evolution, molecular (2) 2
expression (2) 2
gene dosage (2) 2
gene expression profiling (2) 2
genetic heterogeneity (2) 2
genetic variation (2) 2
genome, human (2) 2
greece - epidemiology (2) 2
hematology, oncology and palliative medicine (2) 2
henoch schonlein purpura (2) 2
hepatic encephalopathy (2) 2
hereditary hemorrhagic telangiectasia (2) 2
immunology (2) 2
incidental findings (2) 2
internal medicine (2) 2
kidney neoplasms (2) 2
liver cirrhosis - complications (2) 2
liver diseases (2) 2
melanoma (2) 2
models, statistical (2) 2
natural-history (2) 2
neoplasm staging (2) 2
nursing (2) 2
oncology, experimental (2) 2
phylogeny (2) 2
portal hypertension (2) 2
proportional hazards models (2) 2
renal cell cancer (2) 2
research (2) 2
review article (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Epidemiology, ISSN 1179-1349, 10/2013, Volume 5, Issue 1, pp. 417 - 427
Testicular cancer is a rare tumor type accounting for 1% of malignancies in men. It is, however, the most common cancer in young men in Western populations.... 
Testicular cancer | Mortality | Global | Incidence | Health risk assessment
Journal Article
by Arce Vargas, Frederick and Furness, Andrew J.S and Solomon, Isabelle and Joshi, Kroopa and Mekkaoui, Leila and Lesko, Marta H and Miranda Rota, Enrique and Dahan, Rony and Georgiou, Andrew and Sledzinska, Anna and Ben Aissa, Assma and Franz, Dafne and Werner Sunderland, Mariana and Wong, Yien Ning Sophia and Henry, Jake Y and O’Brien, Tim and Nicol, David and Challacombe, Ben and Beers, Stephen A and Spain, Lavinia and Wotherspoon, Andrew and Francis, Nicholas and Smith, Amy and Smith, Sean and Smith, Myles and Smith, Elaine and Strauss, Dirk and Hayes, Andrew and Soultati, Aspasia and Stares, Mark and Lynch, Joanna and Fotiadis, Nicos and Fernando, Archana and Hazell, Steve and Chandra, Ashish and Pickering, Lisa and Rudman, Sarah and Chowdhury, Simon and Swanton, Charles and Jamal-Hanjani, Mariam and Veeriah, Selvaraju and Shafi, Seema and Czyzewska-Khan, Justyna and Johnson, Benjamin and Johnson, Diana and Laycock, Joanne and Bosshard-Carter, Leticia and Goh, Gerald and Rosenthal, Rachel and Gorman, Pat and Murugaesu, Nirupa and Hynds, Robert E and Wilson, Gareth and Birkbak, Nicolai J and Watkins, Thomas B.K and McGranahan, Nicholas and Horswell, Stuart and Mitter, Richard and Escudero, Mickael and Stewart, Aengus and Van Loo, Peter and Rowan, Andrew and Xu, Hang and Turajlic, Samra and Hiley, Crispin and Abbosh, Christopher and Goldman, Jacki and Stone, Richard Kevin and Denner, Tamara and Matthews, Nik and Matthews, Sue and Elgar, Greg and Ward, Sophia and Biggs, Jennifer and Costa, Marta and Begum, Sharmin and Phillimore, Ben and Chambers, Tim and Nye, Emma and Graca, Sofia and Al Bakir, Maise and Hartley, John A and Lowe, Helen L and Herrero, Javier and Lawrence, David and Hayward, Martin and Panagiotopoulos, Nikolaos and Kolvekar, Shyam and Falzon, Mary and Borg, Elaine and Simeon, Celia and Hector, Gemma and Aranda, Marie and Novelli, Marco and Oukrif, Dahmane and Janes, Sam M and Thakrar, Ricky and Forster, Martin and Ahmad, Tanya and Lee, Siow Ming and ... and Melanoma TRACERx Consortium and Renal TRACERx Consortium and Lung TRACERx Consortium
Immunity, ISSN 1074-7613, 04/2017, Volume 46, Issue 4, pp. 577 - 586
CD25 is expressed at high levels on regulatory T (Treg) cells and was initially proposed as a target for cancer immunotherapy. However, anti-CD25 antibodies... 
regulatory T cells | tumor immunotherapy | anti-CD25 | Treg depletion | inhibitory Fc receptor | CD25 | tumor microenvironment | Fc gamma receptors | anti-PD-1 | EFFECTOR | RESPONSES | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | CANCER-PATIENTS | MELANOMA | MONOCLONAL-ANTIBODY | ANTI-CTLA-4 ANTIBODIES | IMMUNOLOGY | ANTITUMOR-ACTIVITY | COMBINATION | GAMMA-RS | T-Lymphocytes, Regulatory - metabolism | Immunotherapy - methods | Humans | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Lymphocyte Depletion | Receptors, IgG - metabolism | T-Lymphocytes, Regulatory - immunology | Neoplasms - therapy | Flow Cytometry | Immunoglobulin Fc Fragments - immunology | Antibodies, Monoclonal - immunology | Interleukin-2 Receptor alpha Subunit - immunology | Kaplan-Meier Estimate | Programmed Cell Death 1 Receptor - metabolism | Receptors, IgG - immunology | Protein Binding - immunology | Animals | Neoplasms - immunology | K562 Cells | Cell Line, Tumor | Mice | Antibodies, Monoclonal - metabolism | Programmed Cell Death 1 Receptor - immunology | Neoplasms - pathology | Viral antibodies | Cell death | Analysis | Immunotherapy | Antibodies | T cells | Cancer | Fc receptors | Beer | Immunoglobulins | Lymphatic system | Immune response | Cytokines | Melanoma | Light emitting diodes | Lymphocytes T | Anticancer properties | Depletion | Lymphocytes | Tumors | Immune system | Report
Journal Article
Cell, ISSN 0092-8674, 04/2018, Volume 173, Issue 3, pp. 581 - 594.e12
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2011, Volume 38, Issue 5, pp. 473 - 483
Abstract In cancer biology angiogenesis plays a vital role in tumour growth and its subsequent metastatic potential. By targeting the angiogenic process, a new... 
Hematology, Oncology and Palliative Medicine | Platinum compounds | Toxicity | Nitrate-mediated dilatation | Flow-mediated dilatation | Vinca alkaloids | Taxanes | Vascular endothelial growth factor | Antimetabolites | Cytotoxics | Endothelium | TESTICULAR CANCER-PATIENTS | LONG-TERM SURVIVORS | DOXORUBICIN-INDUCED APOPTOSIS | NITRIC-OXIDE SYNTHASE | GERM-CELL TUMORS | CISPLATIN-BASED CHEMOTHERAPY | TUMOR-NECROSIS-FACTOR | PACLITAXEL-ELUTING STENT | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | METASTATIC BREAST-CANCER | Anthracyclines - adverse effects | Taxoids - pharmacology | Humans | Angiogenesis Inhibitors - pharmacology | Endothelium, Vascular - drug effects | Antineoplastic Agents - therapeutic use | Bleomycin - adverse effects | Cyclophosphamide - adverse effects | Antimetabolites - adverse effects | Methotrexate - adverse effects | Taxoids - therapeutic use | Antineoplastic Agents - adverse effects | Vinca Alkaloids - pharmacology | Angiogenesis Inhibitors - therapeutic use | Antineoplastic Agents - pharmacology | Angiogenesis Inhibitors - adverse effects | Platinum Compounds - pharmacology | Antimetabolites - pharmacology | Platinum Compounds - adverse effects | Medical colleges | Care and treatment | Endothelial growth factors | Oncology, Experimental | Research | Chemotherapy | Cardiac patients | Angiogenesis inhibitors | Health aspects | Cancer | Index Medicus
Journal Article
Journal of Oncology Pharmacy Practice, ISSN 1078-1552, 1/2020, Volume 26, Issue 1, pp. 93 - 98
Introduction Drug treatment for cancer has changed dramatically over the past decade with many new drugs often with multiple applications. More recently, the... 
Journal Article
Journal Article
Cell, ISSN 0092-8674, 04/2018, Volume 173, Issue 3, pp. 611 - 623.e17
Journal Article
Cell, ISSN 0092-8674, 04/2018, Volume 173, Issue 3, pp. 595 - 610.e11
Journal Article